Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Aberrant expression and subcellular localization of laminin 332 in oral squamous cell carcinoma: Implications for invasive front assessment.

Medicina oral, patologia oral y cirugia bucal·2026
Same author

A Novel Herbal Nano-Based Ear Drop with <i>Ocimum gratissimum</i> Essential Oil: An Alternative Strategy for Managing Otomycosis.

Pharmaceutics·2026
Same author

Escalating Antifungal Resistance Among <i>Candida</i> Species in Reproductive-Age Women in Vietnam: Implications for Women's Health and Healthcare Systems.

Pathogens (Basel, Switzerland)·2026
Same author

Validated virtual screening models for identifying allosteric inhibitors of ATP-citrate lyase: the role of docking scores and protein-ligand interaction similarity in hit selection.

Molecular diversity·2026
Same author

Biosynthesis and Biological Properties of Nano-Silver from <i>Aspergillus terreus</i> Towards Antibacterial and Antitumor Applications.

Pharmaceutics·2026
Same author

Improved ADME Prediction by Multitask Pretraining on Predicted Data: Insights from the ASAP-Polaris-OpenADMET Blind Challenge.

Journal of chemical information and modeling·2025

相关实验视频

Updated: May 6, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K

针对MAO-B选择性:计算选,对接和分子动力学的洞察力

K-M Thai1,2,3, D-T Pham4, T-M Ngo2,3

  • 1University of Health Sciences, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Vietnam.

SAR and QSAR in environmental research
|August 13, 2025
PubMed
概括

研究人员确定了对单胺氧化酶B (MAO-B) 的新型选择性抑制剂,这对于帕金森病治疗至关重要. 计算方法确定了四种具有潜在治疗益处的有希望的化合物.

关键词:
在2D-QSAR中使用.在MAO-BB中,分子对接的分子对接.分子动态模拟分子动态模拟作为一个药物学家,他做了一些药物学.

更多相关视频

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

527
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K

相关实验视频

Last Updated: May 6, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

527
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K

科学领域:

  • 计算化学是一种计算化学.
  • 神经科学是一个神经科学.
  • 药物发现 药物发现

背景情况:

  • 单胺氧化酶B (MAO-B) 在多巴胺代谢中起着关键作用,是帕金森病的重要治疗点.
  • 开发选择性MAO-B抑制剂对于有效管理帕金森病症状至关重要.

研究的目的:

  • 通过全面的in silico方法,识别新的选择性MAO-B抑制剂.
  • 通过分子动力学和结合自由能计算来评估潜在抑制剂的结合亲和力和稳定性.

主要方法:

  • 一个多阶段的计算工作流程,包括3D-pharmacophore建模,2D-QSAR,ADMET过,分子对接和分子动力学 (MD) 模拟.
  • 使用MM/PBSA分析计算了排名最高的化合物的结合自由能量.
  • 在各种化学数据库 (ZINC,DrugBank,TCM,UNPD) 进行了查.

主要成果:

  • 根据对接分数和对MAO-A的预测选择性,选择了22种顶级候选化合物.
  • 四种化合物 (ZINC21285023,ZINC79651118,ZINC58283019,和UNPD89644/crotafuran E) 经过200 ns的MD模拟后,与关键的MAO-B残留物 (Cys172,Tyr435) 显示出稳定的结合和有利的相互作用.
  • 这些已识别的化合物表现出与已知MAO-B抑制剂萨菲纳米德 (safinamide) 相似或更高的性能.

结论:

  • 该研究成功地通过先进的计算技术识别了四种强效和选择性的MAO-B抑制剂.
  • 这些化合物代表了进一步实验验证和作为帕金森病治疗药物的潜在发展的有希望的候选人.
  • 集成的in silico工作流提供了一个强大的战略,用于发现神经退行性疾病的新药候选者.